Indivior Pharmaceuticals, Inc.
INDV$1.83B
Small CapNASDAQPharmaceutical PreparationsPharmaceutical🇺🇸North AmericaNORTH CHESTERFIELD
Indivior is an American pharmaceuticals company. Established as a division of Reckitt Benckiser in 1994 and demerged from that company in December 2014, it is focussed on substitution products for opioid addiction. It is listed on the London Stock Exchange and on the NASDAQ Global Select Market.
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Jul 30, 2026
5wMarket Overview
Stock performance and key metrics
INDV News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
No drugs found in this phase.
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply